Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis / prepared by Southern California/RAND Evidence-based Practice Center.
Imprint
[Rockville, Md.] : [Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services], [2004]